Literature DB >> 1158033

Decrease in myelin content of rabbit sciatic nerve with aging and diabetes.

N Spritz, H Singh, B Marinan.   

Abstract

Previous studies of the amount of peripheral nerve myelin have been based on histologic examination. In this study, myelin content was measured directly after quantitative isolation from sciatic nerve. There was a decrease in the amount of myelin beginning at nine months, the time of maximal myelin content in normal rabbits, and beginning at six months, the amount was decreased in diabetic as compared with control animals. Composition of myelin isolated from young (age three to four months) and old (age nine to thirteen months) rabbit sciatic nerves was also determined and is similar to that of other species. Although the composition was not affected by diabetes, with aging there was a significant decrease in the amount of cholesterol and an increase in glycolipid.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1158033     DOI: 10.2337/diab.24.7.680

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  4 in total

1.  A defect in sodium-dependent amino acid uptake in diabetic rabbit peripheral nerve. Correction by an aldose reductase inhibitor or myo-inositol administration.

Authors:  D A Greene; S A Lattimer; P B Carroll; J D Fernstrom; D N Finegold
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

Review 2.  [Diabetes mellitus and bladder function. What should be considered?].

Authors:  C Hampel; R Gillitzer; S Pahernik; S Melchior; J W Thüroff
Journal:  Urologe A       Date:  2003-12       Impact factor: 0.639

3.  Axonopathy and microangiopathy in chronic alloxan diabetes.

Authors:  H C Powell; R R Myers
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

4.  The effects of dietary treatment with essential fatty acids on sciatic nerve conduction and activity of the Na+/K+ pump in streptozotocin-diabetic rats.

Authors:  M J Lockett; D R Tomlinson
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.